Speaker illustration

Doctor Panagiota Efstathia Nikolaou

National & Kapodistrian University of Athens, Athens (Greece)

Member of:

European Society of Cardiology

Empagliflozin treatment pre- and post- acute myocardial infarction reduces no-reflow, inflammatory cell infiltration and infarct size while preserving cardiac function.

Event: ESC Congress 2024

Topic: No Reflow

Session: Basic research in acute coronary syndromes

Thumbnail

Discovery and in vivo evaluation of novel inhibitors of the hydrolytic activity of mitochondrial F1Fo ATP synthase to alleviate myocardial ischemia reperfusion injury

Event: ESC Congress 2023

Topic: Ischaemia, Infarction, Cardioprotection

Session: Ischaemia reperfusion

Thumbnail

Empagliflozin restores the deregulated cardiac endothelial cell transcriptome in vivo upon myocardial ischemia reperfusion injury and reduces the infiltration of immune cells.

Event: ESC Congress 2023

Topic: Ischaemia, Infarction, Cardioprotection

Session: Ischaemia reperfusion

Thumbnail

Cardiotoxicity in light chain amyloidosis: Insights from the first murine model with intramyocardial injection of patient-derived amyloidogenic light chains

Event: ESC Congress 2023

Topic: Pathophysiology and Mechanisms

Session: Elucidating basic mechanisms in heart failure

Thumbnail

Cardioprotection by selective SGLT2 inhibitors in a non-diabetic mouse model of myocardial ischemia/reperfusion injury: a class or a drug effect?

Event: ESC Congress 2022

Topic: Ischaemia, Infarction, Cardioprotection

Session: Myocardial ischaemia and protective mechanisms

Thumbnail

Understanding the molecular mosaic of cardiotoxicity of light chains in plasma cell dyscrasias and cardiac light chain amyloidosis with the use of patient derived full-length light chains

Event: ESC Congress 2022

Topic: Cardiomyopathies

Session: Cardiomyopathies

Thumbnail

Empagliflozin rescues primary murine cardiac fibroblasts, but not cardiomyocytes, from hypoxia-reoxygenation injury through STAT3-mediated cascades.

Event: ESC Congress 2022

Topic: Antidiabetic Pharmacotherapy

Session: Anti-diabetic pharmacotherapy in clinical practice

Thumbnail

Al amyloidosis with cardiac involvement: cardiotoxicity of aggregation prone peptides deriving from variable domains of immunoglobulin light chains

Event: ESC Congress 2020

Topic: Cardiotoxicity of Drugs and Other Therapies

Session: Mechanisms of Heart Failure and Implications for Clinical Translation

Thumbnail

Hydrolytic activity of mitochondrial F1Fo ATP synthase as a target for myocardial ischemia: discovery and in vitro evaluation of novel inhibitors

Event: ESC Congress 2020

Topic: Mitochondria

Session: Mitochondria and Metabolism in Cardiovascular Disease

Thumbnail

Investigating the impact of aging and hyperlipidaemia on metformin cardioprotection against carfilzomib-induced cardiotoxicity in vivo

Event: ESC Congress 2020

Topic: Cardiotoxicity of Drugs

Session: Pharmacology and Pharmacotherapy ePosters

Thumbnail